News

At NGM, we pride ourselves on conducting world-class science and sharing our research efforts with the broader scientific and medical communities.

Select section

Oct 04, 2010

NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director

Read more View PDF

Mar 15, 2010

NGM Biopharmaceuticals Raises $51 million in Series B financing and Appoints New Board Member

Read more View PDF